Bile Biochemistry Following Liver Reperfusion in the Recipient and Its Association With Cholangiopathy.


Journal

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
ISSN: 1527-6473
Titre abrégé: Liver Transpl
Pays: United States
ID NLM: 100909185

Informations de publication

Date de publication:
08 2020
Historique:
received: 13 10 2019
revised: 20 01 2020
accepted: 10 02 2020
pubmed: 29 2 2020
medline: 20 3 2021
entrez: 29 2 2020
Statut: ppublish

Résumé

Cholangiocytes secrete bicarbonate and absorb glucose, producing bile with alkaline pH and low glucose content. These functions of cholangiocytes have been suggested as a marker of bile duct viability during normothermic ex situ liver perfusion, and they are now monitored routinely after reperfusion in our center. In this study, we reviewed the composition of bile immediately after reperfusion in liver transplant recipients to determine normal posttransplant parameters and the predictive value of bile biochemistry for the later development of cholangiopathy. After reperfusion of the liver graft, a cannula was placed in the bile duct to collect bile over a median 44-minute time period. The bile produced was analyzed using a point-of-care blood gas analyzer (Cobas b221, Roche Diagnostics, Indianapolis, IN). A total of 100 liver transplants (35 from donation after circulatory death and 65 from donation after brain death) were studied. Median bile pH was 7.82 (interquartile range [IQR], 7.67-7.98); median bile glucose was 2.1 (1.4-3.7) mmol/L; median blood-bile-blood pH difference was 0.50 (0.37-0.62); and median blood-bile glucose difference was 7.1 (5.6-9.1) mmol/L. There were 12 recipients who developed cholangiopathy over a median follow-up of 15 months (IQR, 11-20 months). Bile sodium (142 versus 147 mmol/L; P = 0.02) and blood-bile glucose concentration differences (5.2 versus 7.6 mmol/L; P = 0.001) were significantly lower and were associated with ischemic cholangiopathy. In conclusion, bile biochemistry may provide useful insights into cholangiocyte function and, hence, bile duct viability. Our results suggest bile glucose is the most sensitive predictor of cholangiopathy.

Identifiants

pubmed: 32108995
doi: 10.1002/lt.25738
pmc: PMC7497270
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1000-1009

Informations de copyright

Copyright © 2020 The Authors. Liver Transplantation published by Wiley Periodicals, Inc., on behalf of American Association for the Study of Liver Diseases.

Références

Compr Physiol. 2013 Jan;3(1):541-65
pubmed: 23720296
Am J Transplant. 2019 Nov;19(11):2991-3005
pubmed: 31012532
Clin Res Hepatol Gastroenterol. 2012 Feb;36(1):7-9
pubmed: 22206851
Liver Transpl. 2007 May;13(5):708-18
pubmed: 17457932
Curr Transplant Rep. 2018;5(1):72-81
pubmed: 29564205
Am J Transplant. 2018 Aug;18(8):2005-2020
pubmed: 29419931
Hepatology. 2010 Oct;52(4):1489-96
pubmed: 20721884
Nature. 2018 May;557(7703):50-56
pubmed: 29670285
World J Gastroenterol. 2008 Oct 7;14(37):5641-9
pubmed: 18837079
Transplantation. 2017 May;101(5):1084-1098
pubmed: 28437389
Transplantation. 2019 Jul;103(7):1405-1413
pubmed: 30395120
J Clin Invest. 1974 Feb;53(2):526-35
pubmed: 11344566
Curr Opin Gastroenterol. 2012 May;28(3):253-7
pubmed: 22450897
Hepatology. 1994 Jun;19(6):1400-6
pubmed: 8188169
Am J Transplant. 2016 Jan;16(1):353-7
pubmed: 26393945
Am J Transplant. 2016 Nov;16(11):3235-3245
pubmed: 27192971

Auteurs

Rohit Gaurav (R)

Cambridge Transplant Unit, Addenbrooke's Hospital, Cambridge University Hospitals National Health Service Trust, Cambridge, United Kingdom.

Niroshan Atulugama (N)

Cambridge Transplant Unit, Addenbrooke's Hospital, Cambridge University Hospitals National Health Service Trust, Cambridge, United Kingdom.

Lisa Swift (L)

Cambridge Transplant Unit, Addenbrooke's Hospital, Cambridge University Hospitals National Health Service Trust, Cambridge, United Kingdom.

Andrew J Butler (AJ)

Cambridge Transplant Unit, Addenbrooke's Hospital, Cambridge University Hospitals National Health Service Trust, Cambridge, United Kingdom.
Department of Radiology, Addenbrooke's Hospital, Cambridge University Hospitals National Health Service Trust, Cambridge, United Kingdom.
Department of Pathology, Addenbrooke's Hospital, Cambridge University Hospitals National Health Service Trust, Cambridge, United Kingdom.

Sara Upponi (S)

Department of Pathology, Addenbrooke's Hospital, Cambridge University Hospitals National Health Service Trust, Cambridge, United Kingdom.
Department of Medicine, Addenbrooke's Hospital, Cambridge University Hospitals National Health Service Trust, Cambridge, United Kingdom.

Rebecca Brais (R)

Department of Pathology, Addenbrooke's Hospital, Cambridge University Hospitals National Health Service Trust, Cambridge, United Kingdom.
Department of Surgery, Addenbrooke's Hospital, Cambridge University Hospitals National Health Service Trust, Cambridge, United Kingdom.

Michael Allison (M)

Department of Pathology, Addenbrooke's Hospital, Cambridge University Hospitals National Health Service Trust, Cambridge, United Kingdom.
National Institute for Health Research Cambridge Biomedical Research Centre and the National Institute for Health Research Blood and Transplant Research in Organ Donation and Transplantation, National Health Service Blood and Transplant at University of Cambridge and Newcastle University, Cambridge, United Kingdom.

Christopher J E Watson (CJE)

Cambridge Transplant Unit, Addenbrooke's Hospital, Cambridge University Hospitals National Health Service Trust, Cambridge, United Kingdom.
Department of Radiology, Addenbrooke's Hospital, Cambridge University Hospitals National Health Service Trust, Cambridge, United Kingdom.
Department of Pathology, Addenbrooke's Hospital, Cambridge University Hospitals National Health Service Trust, Cambridge, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH